iBio, Inc. - Common Stock (IBIO)

0.8010
-0.0471 (-5.55%)
NASDAQ · Last Trade: Nov 19th, 4:40 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.8481
Open0.8372
Bid0.7510
Ask0.8164
Day's Range0.7550 - 0.8450
52 Week Range0.6751 - 3.820
Volume421,578
Market Cap27.67M
PE Ratio (TTM)-1.704
EPS (TTM)-0.5
Dividend & YieldN/A (N/A)
1 Month Average Volume525,028

Chart

About iBio, Inc. - Common Stock (IBIO)

Ibio Inc is a biotechnology company that focuses on the development and commercialization of innovative biologic therapies for various diseases. Utilizing its proprietary plant-based expression platform, the company aims to create a range of scalable, cost-effective solutions for producing proteins and antibodies that can be used in therapies and vaccines. Ibio also engages in collaborations and partnerships to accelerate the development of its product pipeline and enhance its technology, ultimately striving to improve patient outcomes in areas such as infectious diseases and cancer. Read More